- Home
- PYN vs DRIO Comparison
PYN vs DRIO Comparison
Compare PYN & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYN
- DRIO
- Stock Information
- Founded
- PYN 2002
- DRIO 2011
- Country
- PYN United States
- DRIO United States
- Employees
- PYN N/A
- DRIO N/A
- Industry
- PYN Investment Managers
- DRIO Medical/Dental Instruments
- Sector
- PYN Finance
- DRIO Health Care
- Exchange
- PYN Nasdaq
- DRIO Nasdaq
- Market Cap
- PYN 30.1M
- DRIO 30.5M
- IPO Year
- PYN N/A
- DRIO N/A
- Fundamental
- Price
- PYN $5.09
- DRIO $0.58
- Analyst Decision
- PYN
- DRIO Strong Buy
- Analyst Count
- PYN 0
- DRIO 2
- Target Price
- PYN N/A
- DRIO $2.50
- AVG Volume (30 Days)
- PYN 19.9K
- DRIO 175.1K
- Earning Date
- PYN 01-01-0001
- DRIO 08-11-2025
- Dividend Yield
- PYN 5.07%
- DRIO N/A
- EPS Growth
- PYN N/A
- DRIO N/A
- EPS
- PYN N/A
- DRIO N/A
- Revenue
- PYN N/A
- DRIO $28,034,000.00
- Revenue This Year
- PYN N/A
- DRIO $20.85
- Revenue Next Year
- PYN N/A
- DRIO $17.09
- P/E Ratio
- PYN N/A
- DRIO N/A
- Revenue Growth
- PYN N/A
- DRIO 47.20
- 52 Week Low
- PYN $4.84
- DRIO $0.50
- 52 Week High
- PYN $6.60
- DRIO $1.55
- Technical
- Relative Strength Index (RSI)
- PYN 35.88
- DRIO 31.86
- Support Level
- PYN $5.05
- DRIO $0.52
- Resistance Level
- PYN $5.12
- DRIO $0.74
- Average True Range (ATR)
- PYN 0.06
- DRIO 0.05
- MACD
- PYN -0.01
- DRIO -0.02
- Stochastic Oscillator
- PYN 14.81
- DRIO 26.48
About PYN PIMCO New York Municipal Income Fund III of Beneficial Interest
PIMCO New York Municipal Income Fund III is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State, and New York City income tax. To pursue the objectives, the fund invests a majority of its net assets in municipal bonds that pay interest that is exempt from federal, New York State, and New York City income tax.
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.